Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
General Dynamics
GD
$107B
| $593M | 0.32% |
2,098,646
-220,876
| -10% | -$59.1M |
|
77
Amdocs
DOX
$5.81B
| $586M | 0.32% |
6,486,680
-27,403
| -0.4% | -$2.5M |
|
78
Ascendis Pharma A/S
ASND
$16.5B
| $569M | 0.31% |
3,767,203
-227,582
| -6% | -$32.5M |
|
79
Mercado Libre
MELI
$94.3B
| $557M | 0.3% |
368,559
+132,028
| +56% | +$216M |
|
80
Honeywell
HON
$78.5B
| $554M | 0.3% |
2,863,210
+214,701
| +8% | +$40.4M |
|
81
Freeport-McMoran
FCX
$89.4B
| $553M | 0.3% |
11,764,419
-162,754
| -1% | -$6.57M |
|
82
Nike
NKE
$63.4B
| $548M | 0.3% |
5,833,783
-533,242
| -8% | -$54.2M |
|
83
Alphabet (Google) Class A
GOOGL
$4.08T
| $545M | 0.3% |
3,614,522
+299,657
| +9% | +$42.9M |
|
|
CTLT
84
DELISTED
CATALENT, INC.
CTLT
| $540M | 0.29% |
9,560,698
-3,688,641
| -28% | -$200M |
|
85
Hilton Worldwide
HLT
$73.7B
| $537M | 0.29% |
2,518,592
-225,976
| -8% | -$44.4M |
|
86
Fortive
FTV
$19.5B
| $537M | 0.29% |
8,285,943
+2,653,724
| +47% | +$161M |
|
87
Alliant Energy
LNT
$19.1B
| $533M | 0.29% |
10,579,475
+984,963
| +10% | +$48.3M |
|
88
Vaxcyte
PCVX
$7.81B
| $524M | 0.29% |
7,673,868
+692,492
| +10% | +$48M |
|
89
ConocoPhillips
COP
$139B
| $508M | 0.28% |
3,987,601
-52,251
| -1% | -$5.96M |
|
90
Illumina
ILMN
$29.1B
| $506M | 0.28% |
3,787,753
-737,894
| -16% | -$98.9M |
|
91
Edwards Lifesciences
EW
$48B
| $504M | 0.28% |
5,276,857
-293,761
| -5% | -$24.7M |
|
92
Lamar Advertising Co
LAMR
$16.5B
| $499M | 0.27% |
4,175,726
-418,377
| -9% | -$45.9M |
|
93
Intuit
INTU
$85.5B
| $491M | 0.27% |
755,567
-12,175
| -2% | -$7.77M |
|
94
Rentokil
RTO
$14.5B
| $487M | 0.27% |
16,139,724
+105,248
| +0.7% | +$2.92M |
|
95
HCA Healthcare
HCA
$92.2B
| $477M | 0.26% |
1,430,693
-121,564
| -8% | -$37.1M |
|
96
Microchip Technology
MCHP
$41.9B
| $476M | 0.26% |
5,306,131
-328,399
| -6% | -$28.3M |
|
|
97
DoorDash
DASH
$84B
| $476M | 0.26% |
3,455,116
+3,425,115
| +11,417% | +$403M |
|
98
CME Group
CME
$93.3B
| $467M | 0.25% |
2,167,342
-800,889
| -27% | -$168M |
|
|
99
Applied Materials
AMAT
$383B
| $465M | 0.25% |
2,254,952
+1,259,111
| +126% | +$231M |
|
100
TE Connectivity
TEL
$62.1B
| $451M | 0.25% |
3,105,369
-391,267
| -11% | -$54.8M |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.